Impressive breakthrough in cancer treatment research.
Questions about Immunocore
What is Immunocore?
Immunocore is a commercial-stage biotechnology company based in Abingdon, England, that pioneers and delivers transformative immunomodulating medicines. The company focuses on the discovery and development of novel T cell receptor-based drugs to treat diseases with a high unmet need, including cancer and viral disease. Their proprietary ImmTAX technology platform allows them to upregulate the immune system to tackle cancer or infectious diseases, or downregulate it to address autoimmune conditions.
What specific therapies or products are currently in development?
The company's first product candidate, IMCgp100, entered clinical trials in patients with metastatic melanoma. They have a diverse pipeline with multiple bispecific T cell receptor therapies across a range of indications, from solid tumors to infectious and autoimmune diseases. Their proprietary ImmTAX technology is modular, allowing them to tune the immune system up or down to target various conditions.
Where is Immunocore located and which countries do they serve?
Immunocore's headquarters are located at 101 Park Drive in Abingdon, Oxfordshire, UK. They also maintain offices in Pennsylvania and Maryland, US, as well as locations in Dublin, Ireland, Zug, Switzerland, and Oxfordshire, UK. The company operates globally to serve patients with cancer, infectious diseases, and autoimmune diseases.
What is the current Trustburn rating and how recent are the reviews?
The Trustburn rating for Immunocore is 4.1 out of 5 stars, based on 11 reviews. The reviews are from 2022 and 2023, with the most recent one dated November 9, 2023. The rating split shows a majority of 4 and 5-star ratings, with some 3-star reviews included.
What aspects of Immunocore do reviewers most frequently praise?
Reviewers consistently praise Immunocore for their team's expertise, attention to detail, and professional responsiveness. Many customers highlight the exceptional service, top-notch talent, and dedication to delivering high-quality results. The team is described as knowledgeable, innovative, and committed to ensuring project success.
What themes emerge from the customer reviews?
Some reviewers mention that the service provided was exceptional and that the team went above and beyond to ensure project success. Others note the impressive breakthroughs in cancer treatment research and the game-changing impact of their innovative solutions. The overall sentiment is highly positive regarding collaboration and outcomes.
What makes Immunocore's technology platform unique?
Immunocore's proprietary ImmTAX technology, also known as Immune Mobilizing Monoclonal TCRs Against X disease, is their core innovation. This platform is based on research from the University of Oxford in the 1990s and allows for modular therapy design. It enables the company to create bispecific therapies that can target cancer, infectious diseases, and autoimmune diseases.
Who are Immunocore's key partners and what are their partnership goals?
The company has a strong history of creating value through partnerships with industry, academia, and the charitable sector. Past and present partners include Genentech, GSK, and the Bill & Melinda Gates Foundation. They are currently focusing on partnerships that combine clinical stage assets to shift patient benefit and enhance their proprietary platform.
What recent clinical trial updates have Immunocore announced?
Immunocore is presenting promising data from Phase 1/2 trial cohorts evaluating brenetafusp plus KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma. They also announced the first patient dosed in the Phase 1 trial of IMC-S118AI for type 1 diabetes and achieved target enrollment in the registrational TEBE-AM trial with KIMMTRAK in advanced melanoma.
When are Immunocore's upcoming investor events and financial reports scheduled?
The company will present at upcoming investor conferences in November 2026 and will report second quarter 2026 financial results in July 2026. They also plan to present Phase 1 data for brenetafusp at the 2026 SITC meeting in October 2026. These events are part of their ongoing communication with investors and stakeholders.
How long has Immunocore been operating and what is their mission?
Immunocore is a commercial-stage biotechnology company that has been active since at least 2022, when they launched the world's first TCR therapy. The company has a diverse pipeline and is focused on radically improving outcomes for patients with cancer, infectious diseases, and autoimmune diseases. Their mission is to pioneer and deliver transformative immunomodulating medicines.
How does the ImmTAX platform work for different disease types?
Immunocore's ImmTAX platform can be used to upregulate the immune system to tackle cancer (ImmTAC) or infectious diseases (ImmTAV), and downregulate it to address autoimmune conditions (ImmTAAI). This modular approach allows them to create therapies for a broad range of indications, including multiple cancers, HIV, and HBV.
How can I contact Immunocore?
You can reach Immunocore by phone at +44 (0)1235 438600 or by e-mail at [email protected].
What is the official website of Immunocore?
The official website of Immunocore is immunocore.com.
Is Immunocore on social media?
Immunocore has official profiles on Linkedin.
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
Based on reviews, listing data and the company's website. Verify anything important with the company directly.
I recently had the opportunity to work with Immunocore and I have nothing but positive things to say about them. The team was professional, knowledgeable, and very responsive. They truly went above and beyond to ensure the success of our project. I highly recommend Immunocore and look forward to working with them again in the future.
I had the pleasure of working with Immunocore and I couldn't be happier with the experience. Their team's expertise and attention to detail are outstanding. I look forward to future collaborations with them.
👍 I'm absolutely impressed with Immunocore! Their team is top-notch and they provide exceptional service. I couldn't be happier with the outcome of our collaboration. Highly recommended! 👏
I had a great experience with this company. Their expertise and dedication to their work are truly impressive. They provided excellent service and I'm very satisfied with the result. I will definitely recommend them to others.
Immunocore has been a game-changer for us. Their expertise and innovative solutions have significantly impacted our success. We are extremely grateful for their exceptional service. I highly recommend Immunocore.
I recently worked with a company for a project similar to Immunocore. Their team was professional, knowledgeable, and very responsive. They provided outstanding service and I'm extremely satisfied with the result. Highly recommended.
The service provided by Immunocore was exceptional. Their dedication and commitment to delivering top-quality results are commendable. I highly endorse Immunocore and would work with them again without hesitation.
Working with Immunocore has been an absolute pleasure. Their expertise and attention to detail are truly remarkable. I highly value their commitment to delivering high-quality results. I look forward to future collaborations with them.
👌 The experience of working with Immunocore was fantastic! Their team is extremely talented and dedicated. They provided outstanding service and I'm truly impressed. I can't wait for future collaborations! 😊
🙌 Immunocore exceeded all my expectations! Their team is incredibly talented and their service is impeccable. I'm thrilled with the outcome of our collaboration. Highly recommended! 🎉
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
About Immunocore
Immunocore is a focused on the discovery and development of novel T cell receptor-based drugs to treat diseases with a high unmet need, including cancer and viral disease. The Company’s world-leading expertise in engineering T Cell Receptors (TCRs) and linking them to an antibody fragment (scFv) known as anti-CD3, has led to its first product candidate, IMCgp100, entering clinical trials in patients with metastatic melanoma. The proprietary T Cell Receptor technology platform is well validated and can easily be manufactured for clinical and commercial supply in microbial systems.
- Website
- immunocore.com
- Phone
- +44 (0)1235 438600
- [email protected]
- Address
- 101 park drive
- Categories
- Biotechnology


